Lewy Body Dementia Treatment Market Competition Landscape - Key Insights 2018 - 2028

1
Lewy Body Dementia Treatment Market Forecast,
Trend Analysis Competition Tracking - Global
Market Insights 2018 - 2028

• Healthcare
• 17O Pages
• Published Mar 2019

2
Market Snapshot
3
Description

• The Fact.MR study report on lewy body dementia
  treatment market offers an exhaustive analysis
  and assessment on worldwide lewy body dementia
  treatment market, which has been compiled with
  the aid of a proven and tested research
  methodology that includes primary and secondary
  phases.
• This research methodology helped the analysts
  arrive at perceptive insights into the growth
  course of lewy body dementia treatment market
  during the foreseeable period.

4
Key Insights

• Global sales of lewy body dementia treatment were
  valued at over US 3,500 Mn in 2018, in line with
  wide-spread prevalence of lewy body dementia and
  subsequent need for effective treatment.
• Cholinesterase inhibitors, valued at over US
  2,100 Mn in 2018, will continue to remain
  the most lucrative category, followed by
  antipsychotic drugs. The minimal side effects
  associated with these two drug types are among
  the key reasons fuelling demand for these
  products.
• North America will remain the largest market for
  lewy body dementia treatment in 2019 and beyond,
  owing to appropriate dementia drug regulations
  and superior healthcare infrastructure in the
  region.

5
The Competitive Landscape

• Swedish research-based biopharma company,
  BioArctic AB, announced that AbbVie has attained
  the FDA approval of IND application for ABBV-0805
  for the treatment of individuals with Parkinsons
  disease. The alpha-synuclein-targeting ABBV-0805
  is the most advanced treatment in-licensed by
  AbbVie from BioArctic in December 2018. The
  antibody has been evaluated as a disease
  modifying treatment for Parkinson's disease.
• Sumitomo Dainippon Pharma Co., Ltd., a
  Japan-based pharmaceutical company, has signed a
  joint research agreement with Aikomi, Ltd. to
  build medical devices to relieve and prevent
  behavioral and psychological symptoms of
  dementia.
• Takeda Pharmaceutical Company Limited has
  announced the completion of acquisition of Shire
  plc. With this acquisition, Takeda Pharmaceutical
  has become a global, value-based, research and
  development driven biopharmaceutical leader
  headquartered in Japan. 

6
Table of Contents

• 1. Executive Summary      1.1. Global Market
  Outlook      1.2. Demand Side Trends      1.3.
  Supply Side Trends            1.4. Indication
  Roadmap      1.5. Analysis and Recommendations
• 2. Market Overview      2.1. Market Coverage /
  Taxonomy      2.2. Market Definition / Scope /
  Limitations
• 3. Key Market Trends      3.1. Key Trends
  Impacting the Market      3.2. Drug Innovation /
  Key Development Trends
• 4. Key Success Factors      4.1. Pipeline
  Assessment      4.2. Disease Treatment
  Pathophysiology      4.3. Key Regulations     
  4.4. Disease Epidemiology

7

• 5. Global Lewy Body Dementia Treatment Market
  Demand (in Value or Size in US Mn) Analysis
  2013-2017 and Forecast, 2018-2028      5.1.
  Historical Market Value (US Mn) Analysis,
  2013-2017      5.2. Current and Future Market
  Value (US Mn) Projections, 2018-2028           
   5.2.1. Y-o-Y Growth Trend Analysis           
   5.2.2. Absolute Opportunity Analysis
• 6. Market Background      6.1. Macro-Economic
  Factors             6.1.1. Global GDP Growth
  Outlook             6.1.2. Global Healthcare
  Expenditure Outlook      6.2. Forecast Factors -
  Relevance Impact             6.2.1.
  Expenditure on RD by Pharmaceutical Companies  
             6.2.2. Cost of Drugs           
   6.2.3. Merger and Acquisitions           
   6.2.4. Collaborative Agreements ..

8

• Scope
• The scope of Fact.MRs report is to analyze the
  Lewy Body Dementia Treatment market for the
  forecast period 2018-2028 and provide readers an
  unbiased and accurate analysis. Lewy Body
  Dementia Treatment manufacturers, stakeholders,
  and suppliers involved in the Lewy Body Dementia
  Treatment market can benefit from the analysis
  offered in this report. This report offers a
  comprehensive analysis, which can be of interest
  to incumbent players and new entrants looking to
  enter the Lewy Body Dementia Treatment market.
• Summary
• The report commences with a brief information of
  the Lewy Body Dementia Treatment market. This
  executive summary sets the tone for the rest of
  the report, providing users the scope of the
  report. The executive summary includes important
  facts and statistics on the Lewy Body Dementia
  Treatment market.

Request Free Sample Report
9
Get In Touch

• Want Tailor-made Report?
• Enquire at sales_at_factmr.com Now!
• Suite 9884 27 Upper Pembroke Street,
  Dublin 2, Ireland
• Toll Free 353-1-6111-593Email
  sales_at_factmr.comWebsite https//www.factmr.com/